Use of FLOSEAL ® as a scaffold and its impact on induced neural stem cell phenotype, persistence, and efficacy-Reference-Cited by-同舟云学术

Use of FLOSEAL ® as a scaffold and its impact on induced neural stem cell phenotype, persistence, and efficacy

Published:2022-01-21 Issue: Volume: Page:
ISSN:2380-6761
Container-title:Bioengineering & Translational Medicine
language:en
Short-container-title:Bioengineering & Transla Med

Author:

Bomba Hunter N.¹^ORCID,Carey‐Ewend Abigail¹,Sheets Kevin T.¹,Valdivia Alain¹,Goetz Morgan¹,Findlay Ingrid A.¹,Mercer‐Smith Alison¹,Kass Lauren E.¹^ORCID,Khagi Simon²,Hingtgen Shawn D.¹³

Affiliation:

1. Division of Pharmacoengineering and Molecular Pharmaceutics UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

2. Department of Neurosurgery The University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

3. Lineberger Comprehensive Cancer Center The University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

Funder

Foundation for the National Institutes of Health

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/btm2.10283

Reference51 articles.

1. Glioblastoma multiforme: Pathogenesis and treatment

2. Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies

3. Glioblastoma multiforme: the terminator;Holland EC;PNAS,2000

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining the constitutive TRAIL-secreting induced neural stem cell therapy with the novel anti-cancer drug TR-107 in glioblastoma;Molecular Therapy: Oncology;2024-09

2. Development of a biocompatible 3D hydrogel scaffold using continuous liquid interface production for the delivery of cell therapies to treat recurrent glioblastoma;Bioengineering & Translational Medicine;2024-07-30

3. Current approaches in enhancing TRAIL therapies in glioblastoma;Neuro-Oncology Advances;2023-01-01

4. Injectable pH Thermo-Responsive Hydrogel Scaffold for Tumoricidal Neural Stem Cell Therapy for Glioblastoma Multiforme;Pharmaceutics;2022-10-20